Skip to content

ICAAC: Nevirapine still present in breastmilk two weeks after last dose

ICAAC: Achillion reveals potential for once weekly dosing of nucleoside analogue

South African study finds many patients die waiting for treatment after enrolment into antiretroviral rollout programme

ICAAC: Nevirapine and rifampicin can be safely used together

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Advocacy groups demand equal HIV treatment access for injecting drug users

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

Primary drug resistance has limited effect on disease progression and response to treatment

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert